Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pediatrics, |
RCV000844837 | SCV000966117 | pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2019-05-05 | criteria provided, single submitter | research | |
Invitae | RCV000844837 | SCV001590397 | pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2023-05-12 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 375 of the ACAT1 protein (p.Asn375Ser). RNA analysis indicates that this missense change induces altered splicing and likely disrupts the C-terminus of the protein. For these reasons, this variant has been classified as Pathogenic. Studies have shown that this missense change results in activation of a cryptic splice site and introduces a new termination codon (PMID: 18511318). However the mRNA is not expected to undergo nonsense-mediated decay. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ACAT1 protein function. ClinVar contains an entry for this variant (Variation ID: 666528). This missense change has been observed in individual(s) with beta-ketothiolase deficiency (PMID: 18511318, 27928777, 30835345). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs373771053, gnomAD 0.009%). |
Kasturba Medical College, |
RCV000844837 | SCV002053773 | likely pathogenic | Deficiency of acetyl-CoA acetyltransferase | criteria provided, single submitter | clinical testing | ||
Prevention |
RCV003396461 | SCV004105742 | pathogenic | ACAT1-related disorder | 2022-08-25 | criteria provided, single submitter | clinical testing | The ACAT1 c.1124A>G variant is predicted to result in the amino acid substitution p.Asn375Ser. This variant has been reported in the homozygous state in at least two individuals with mitochondrial Acetoacetyl-CoA thiolase deficiency (Fukao et al 2008. PubMed ID: 18511318; Abdelkreem E et al 2017. PubMed ID: 27928777). Functional studies have shown that this variant activates a cryptic splice donor site 5 bases upstream from c.1124A>C within exon 11, causing aberrant splicing with a frameshift (Fukao et al. 2008. PubMed ID: 18511318). This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-108017047-A-G). This variant is interpreted as pathogenic. |
Baylor Genetics | RCV000844837 | SCV004210386 | pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2024-03-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000844837 | SCV002090054 | pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2021-08-05 | no assertion criteria provided | clinical testing | |
Neonatal Disease Screening Center, |
RCV000844837 | SCV004800845 | pathogenic | Deficiency of acetyl-CoA acetyltransferase | no assertion criteria provided | clinical testing | PS3+PM2_P+PM3_S+PP4 |